Assessing the efficacy of molecularly targeted agents on cell line-based platforms by using system identification

BACKGROUND: Molecularly targeted agents (MTAs) are increasingly used for cancer treatment, the goal being to improve the efficacy and selectivity of cancer treatment by developing agents that block the growth of cancer cells by interfering with specific targeted molecules needed for carcinogenesis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiangfang, Qian, Lijun, Hua, Jianping, Bittner, Michael L, Dougherty, Edward R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481481/
https://www.ncbi.nlm.nih.gov/pubmed/23134733
http://dx.doi.org/10.1186/1471-2164-13-S6-S11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481481/
https://www.ncbi.nlm.nih.gov/pubmed/23134733
http://dx.doi.org/10.1186/1471-2164-13-S6-S11

Ejemplares similares